Skip to main content

Advertisement

Log in

CD4+CD7 leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death

  • Original Manuscript
  • Published:
Leukemia Submit manuscript

Abstract

In early stages of cutaneous T cell lymphoma (Sézary syndrome) both CD4+CD7 and CD4+CD7+ T cells clonally expand whereas in late stages of the disease CD7 cells are predominant in number, giving rise to the question whether CD7 T cells have a survival advantage in the skin. Galectin-1, a cell-bound lectin, was recently reported to trigger apoptosis in activated CD7+ T cells. Here, we demonstrate that in contrast to activated CD7+ T cells, quiescent and activated CD69+ CD7 T cells from healthy donors and from Sézary patients are resistant to galectin-1-mediated cell death. CD7 T cells are apoptosis-resistant even during coculture with IFN-γ-stimulated endothelial cells that constitutively express galectin-1 in high amounts. These data imply that resistance of CD7 T cells to galectin-1-induced apoptosis may contribute to the accumulation of CD7 Sézary T cells during progression of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Willemze R, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Pérez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ . EORTC classification for primary cutaneous lymphoma: a proposal from the cutaneous study group of the European organisation for research and treatment of cancer Blood 1997 90: 354–371

    CAS  PubMed  Google Scholar 

  2. Diamandidou E, Cohen PR, Kurzrock R . Mycosis fungoides and Sezary syndrome Blood 1996 88: 2385–2409

    CAS  PubMed  Google Scholar 

  3. Reinhold U, Abken H . CD4+CD7 T cells: a separate subpopulation of memory T cells? J Clin Immunol 1997 17: 265–271

    Article  CAS  Google Scholar 

  4. Bogen SA, Pelley D, Charif M, McCusher M, Koh H, Foss F, Garifallou M, Arkin C, Zucker-Franklin D . Immunophenotypic identification of Sezary cells in peripheral blood Am J Clin Pathol 1996 106: 739–748

    Article  CAS  Google Scholar 

  5. Harmon CB, Witzig TE, Katzmann JA, Pittelkow MR . Detection of circulating T cells with CD4+CD7 immunophenotype in patients with benign and malignant lymphoproliferative dermatoses J Am Acad Dermatol 1996 35: 404–410

    Article  CAS  Google Scholar 

  6. Rappl G, Muche JM, Abken H, Sterry W, Tilgen W, Ugurel S, Reinhold U . CD4+CD7 T cells compose the dominant T cell clone in the peripheral blood of patients with Sézary syndrome J Am Acad Dermatol 2001 44: 456–461

    Article  CAS  Google Scholar 

  7. Nowell PC, Moore JS . Aberrant responses of human lymphocytic neoplasms to cytokine regulation Immunol Res 1998 17: 171–177

    Article  CAS  Google Scholar 

  8. Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-Boitrel MT, Garrido C . Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies Leukemia 2000 14: 1833–1849

    Article  CAS  Google Scholar 

  9. Dereure O, Portales P, Clot J, Guilhou JJ . Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas Br J Dermatol 2000 143: 1205–1210

    Article  CAS  Google Scholar 

  10. Dummer R, Michie S, Kell D, Gould JW, Haeffner AC, Smoller BR, Warnke RA, Wood GS . Expression of BCL-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous infiltrates J Cutan Pathol 1995 22: 11–17

    Article  CAS  Google Scholar 

  11. Osella-Abate S, Zaccagna A, Savoia P, Quaglino P, Salomone B, Bernengo MG . Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy J Am Acad Dermatol 2001 44: 40–47

    Article  CAS  Google Scholar 

  12. Garatti SA, Roscetti E, Trecca D, Fracchiolla NS, Neri A, Berti E . bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas Rec Res Cancer Res 1995 139: 249–261

    Article  CAS  Google Scholar 

  13. Kamarashev J, Burg G, Kempf W, Hess Schmid M, Dummer R . Comparative analysis of histological and immunohistological features in mycosis fungoides and Sézary syndrome J Cutan Pathol 1998 25: 407–412

    Article  CAS  Google Scholar 

  14. Dobbeling U, Dummer R, Laine E, Potoczna N, Qin JZ, Burg G . interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells Blood 1998 92: 252–258

    CAS  PubMed  Google Scholar 

  15. Rappl G, Abken H, Hasselmann DO, Tilgen W, Ugurel S, Reinhold U . The CD7− subset of CD4+ memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15) Cell Death Differ 2001 8: 395–402

    Article  CAS  Google Scholar 

  16. Marincola FM, Jaffeee EM, Hicklin DJ, Ferrone S . Escape of solid human tumors from T-cell recognition: molecular mechanisms and functional significance Adv Immunol 2000 74: 181–273

    Article  CAS  Google Scholar 

  17. Muschen M, Warskulat U, Beckmann MW . Defining CD95 as a tumor suppressor gene J Mol Med 2000 78: 312–325

    Article  CAS  Google Scholar 

  18. Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG . CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death J Immunol 2000 165: 2331–2334

    Article  CAS  Google Scholar 

  19. Perillo NL, Pace KE, Seilhamer JJ, Baum LG . Apoptosis of T cells mediated by galectin-1 Nature 1995 378: 736–739

    Article  CAS  Google Scholar 

  20. Pace KE, Baum LG . Induction of T lymphocyte apoptosis: a novel function for galectin-1 Trends Glycosci Glycotechnol 1997 9: 21–29

    Article  CAS  Google Scholar 

  21. Gabius HJ . Biological information transfer beyond the genetic code: the sugar code Naturwissenschaften 2000 87: 108–121

    Article  CAS  Google Scholar 

  22. Allen HJ, Karakousis C, Piver MS, Gamarra M, Nava H, Forsyth B, Matecki B, Jazayeri A, Sucato D, Kisailus E . Galactoside-binding lectin in human tissues Tumour Biol 1987 8: 218–229

    Article  CAS  Google Scholar 

  23. André S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius HJ . Galectins-1 and -3 and their ligands in tumor biology J Cancer Res Clin Oncol 1999 125: 461–474

    Article  Google Scholar 

  24. Kaltoft K, Bisballe S, Rasmussen HF, Thestrup-Pedersen K, Thomsen K, Sterry W . A continuous T-cell line from a patient with Sezary syndrome Arch Dermatol Res 1987 279: 293–298

    Article  CAS  Google Scholar 

  25. Reinhold U, Abken H, Kukel S, Moll M, Müller R, Oltermann I, Kreysel HW . CD7 T cells represent a subset of normal human blood lymphocytes J Immunol 1993 150: 2081–2089

    CAS  PubMed  Google Scholar 

  26. Gabius HJ . Influence of type of linkage and spacer on the interaction of β-galactoside-binding proteins with immobilized affinity ligands Anal Biochem 1990 189: 91–94

    Article  CAS  Google Scholar 

  27. Gabius HJ, Engelhardt R, Rehm S, Cramer F . Biochemical characterization of endogenous carbohydrate-binding proteins from spontaneous murine rhabdomyosarcoma, mammary adenocarcinoma, and ovarian teratoma J Natl Cancer Inst 1984 73: 1349–1357

    CAS  PubMed  Google Scholar 

  28. Sacchettini JC, Baum LG, Brewer CF . Multivalent protein-carbohydrate interactions. A new paradigm for supermolecular assembly and signal transduction Biochemistry 2001 40: 3009–3015

    Article  CAS  Google Scholar 

  29. Pace KE, Lee C, Stewart PL, Baum LG . Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1 J Immunol 1999 163: 3801–3811

    CAS  PubMed  Google Scholar 

  30. Rabinovich GA, Iglesias MM, Modesti NM, Castagna LF, Wolfenstein-Todel C, Riera CM, Sotomayor CE . Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization J Immunol 1998 160: 4831–4840

    CAS  Google Scholar 

  31. Baum LG, Seilhamer JJ, Pang M, Levine WB, Beynon D, Berliner JA . Synthesis of an endogenous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation Glycoconj J 1995 12: 63–68

    Article  CAS  Google Scholar 

  32. Debbage PL, Gabius HJ, Bise K, Marguth F . Cellular glycoconjugates and their potential endogenous receptors in the cerebral microvasculature of man: a glycohistochemical study Eur J Cell Biol 1988 46: 425–434

    CAS  PubMed  Google Scholar 

  33. Lotan R, Belloni PN, Tressler RJ, Lotan D, Xu XC, Nicolson GL . Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion Glycoconj J 1994 11: 462–468

    Article  CAS  Google Scholar 

  34. Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, Bui TN, Baum LG . CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans J Immunol 2001 167: 5697–5707

    Article  CAS  Google Scholar 

  35. He YW, Bevan MJ . High level expression of CD43 inhibits T cell receptor/CD3-mediated apoptosis J Exp Med 1999 190: 1903–1908

    Article  CAS  Google Scholar 

  36. Mukasa R, Homma T, Ohsuki T, Hosono O, Souta A, Kitamura T, Fukuda M, Watanabe S, Morimoto C . Core 2-containing O-glycans on CD43 are preferentially expressed on the memory subset of human CD4 T cells Int Immunol 1999 11: 259–268

    Article  CAS  Google Scholar 

  37. Macon WR, Casey TT, Kinney MC, Collins RD, Cousar JB . Leu-22 (L60). A more sensitive marker than UCHL1 for peripheral T cell lymphomas, particularly large-cell types Am J Clin Pathol 1991 95: 696–701

    Article  CAS  Google Scholar 

  38. Gelb AB, Smoller BR, Warnke RA, Picker LJ . Lymphocytes infiltrating primary cutaneous neoplasms selective express the cutaneous lymphocyte-associated antigen (CLA) Am J Pathol 1993 142: 1556–1564

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Davis RE, Smoller BR . T lymphocytes expressing HECA-452 epitope are present in cutaneous acute graft-versus-host disease and erythema multiforme, but not in acute graft-versus-host disease in gut organs Am J Pathol 1992 141: 691–698

    CAS  PubMed  PubMed Central  Google Scholar 

  40. McCusker ME, Garifallou M, Bogen SA . Sezary lineage cells can be induced to proliferate via CD28-mediated costimulation J Immunol 1997 158: 4984–4991

    CAS  PubMed  Google Scholar 

  41. Rabinovich GA, Alonso CR, Sotomayor CE, Durand S, Bocco JL, Riera CM . Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the transcription factor and downregulation of bcl-2 Cell Death Differ 2000 8: 747–753

    Article  Google Scholar 

  42. White MK, McCubrey JA . Suppression of apoptosis: role in cell growth and neoplasia Leukemia 2001 15: 1011–1021

    Article  CAS  Google Scholar 

  43. Johnson DE . Programmed cell death regulation: basic mechanisms and therapeutic opportunities Leukemia 2000 14: 1340–1344

    Article  CAS  Google Scholar 

  44. Fadeel B, Orrenius S, Zhivotovsky B . The most unkindest cut of all: on the multiple roles of mammalian caspases Leukemia 2000 14: 1514–1525

    Article  CAS  Google Scholar 

  45. Daniel PT . Dissecting the pathways to death Leukemia 2000 14: 2035–2044

    Article  CAS  Google Scholar 

  46. Dummer R, Nestle FO, Niederer E, Ludwig E, Laine E, Grundmann H, Grob P, Burg G . Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7 T lymphocyte subsets in Sézary syndrome Arch Dermatol Res 1999 291: 307–311

    Article  CAS  Google Scholar 

  47. Hoyer JD, Ross CW, Li CY, Witzig TE, Gascoyne RD, Dewald GW, Hanson CA . True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases Blood 1995 86: 1163–1169

    CAS  PubMed  Google Scholar 

  48. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB . Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL) Leukemia 1995 9: 1783–1786

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mrs K Hilgert for excellent technical assistance. We are grateful to the Bender-Stiftung, Munich, (to HA) and the Wilhelm-Sander-Stiftung, Munich, for financial support. This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (Re 690/4–2).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rappl, G., Abken, H., Muche, J. et al. CD4+CD7 leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia 16, 840–845 (2002). https://doi.org/10.1038/sj.leu.2402438

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402438

  • Springer Nature Limited

Keywords

This article is cited by

Navigation